Premium
Cosmetics and Health • 8 min min read

Endocrine Disruptors in Cosmetics — What Are They and Do They Really Mess With Your Hormones?

What are endocrine disruptors, which cosmetic ingredients raise concern and how is real risk assessed? Phthalates, benzophenone-3, BPA — facts vs social media panic.

Published: 2024-10-05 • Updated: 2026-03-02

The term “endocrine disruptors” — also known as endocrine-disrupting chemicals (EDCs) — crops up on social media so often that it is easy to come away thinking every product on the shelf is a hormonal time bomb. Yet between a substance's potential endocrine activity and a genuine threat to health lies a gulf well worth understanding.

What exactly are endocrine-disrupting chemicals?

The WHO definition from 2002 (International Programme on Chemical Safety) describes EDCs as exogenous substances or mixtures that alter the function of the endocrine system and consequently cause adverse health effects in an intact organism, its progeny or (sub)populations. The key word is “adverse” — simply interacting with a receptor does not automatically mean harm.

The endocrine system regulates reproduction, metabolism, brain development and homeostasis. A substance can act on this system in many ways: mimic a hormone (agonist activity), block a receptor (antagonist activity), or interfere with the synthesis or transport of a hormone. However, every one of these interactions is governed by the dose-response principle — and it is precisely the dose that social media most often leaves out.

BPA — the face of the debate, but not a cosmetic ingredient

Bisphenol A (BPA) is probably the most recognisable endocrine disruptor in the world. In 2023, EFSA (the European Food Safety Authority) drastically lowered the tolerable daily intake of BPA to 0.2 ng/kg of body weight — 20,000 times below the previous limit. That is a major revision based on new data about effects on the immune system.

It is essential, however, to underline one fundamental fact: BPA is not used as a cosmetic ingredient. It may appear in trace amounts in packaging, but it is not an ingredient in a product's formula. When an influencer says “your cream contains BPA,” they are usually confusing exposure sources — the main route of BPA exposure is food in contact with materials containing the substance (cans, thermal receipts), not cosmetics.

Phthalates — DEP as a fragrance ingredient

Phthalates are a group of esters of phthalic acid that serve various functions. In cosmetics we mainly encounter diethyl phthalate (DEP), used as a carrier and fixative for fragrance compositions. You won't find it under its own name on the INCI ingredient list — it hides under the generic term “parfum” or “fragrance.”

An important distinction: the longer-chain phthalates — DEHP, DBP, BBP — are substances with proven anti-androgenic activity in rodents and have been banned from cosmetics in the EU since 2004 (Regulation 1223/2009, Annex II). DEP, with its short chain, shows far lower endocrine activity. A meta-analysis by Engel et al. (2021, Environmental Health Perspectives) confirmed that the evidence for an effect of DEP on human reproduction at cosmetic exposure levels remains inconclusive.

In its 2019 opinion, the SCCS (Scientific Committee on Consumer Safety) assessed DEP as safe at the concentrations currently used in cosmetics, with a margin of safety (MoS) exceeding the required 100.

UV filters — benzophenone-3 under the microscope

Benzophenone-3 (BP-3, oxybenzone) is the UV filter that stirs up the greatest controversy among the endocrine-disrupting chemicals found in cosmetics. In vitro studies have shown its ability to bind to the estrogen receptor, and population biomonitoring (NHANES, CDC) has detected BP-3 metabolites in the urine of more than 96% of Americans tested.

However — and this is crucial — in its 2021 opinion (SCCS/1625/20) the SCCS concluded that using BP-3 at concentrations up to 6% in sunscreen products (lowered from the earlier 10%) provides an adequate margin of safety. The decision rested on data covering dermal absorption, metabolism and cross-species extrapolation. The committee took into account an “aggregate exposure” scenario — the combined exposure from all cosmetic products used daily.

It is worth comparing potency: the estrogenic activity of BP-3 is estimated at 1/10,000 to 1/1,000,000 of the activity of natural estradiol (Schlumpf et al., 2001, Toxicology). To achieve an endocrine effect comparable to a single contraceptive pill, you would have to absorb kilograms of pure BP-3.

The dose-response principle — the key to risk assessment

Paracelsus put it 500 years ago, and the principle remains the foundation of toxicology: the dose makes the poison. In the context of EDCs, this means that a substance's mere ability to interact with a hormone receptor does not determine the health risk.

The SCCS applies a multi-step safety assessment process. First it establishes the NOAEL (No Observed Adverse Effect Level) from animal studies, then divides it by uncertainty factors (usually 100: 10 for interspecies differences × 10 for individual variability) to obtain the margin of safety. A substance with an MoS ≥ 100 is considered safe at the given concentration and pattern of use.

This system is not perfect — it does not fully account for the “cocktail effect” or non-monotonic dose-response curves. But it is the best available scientific model, regularly updated as new data emerge.

Social media panic vs science

Social media algorithms reward emotional content. A post saying “this cream disrupts your hormones!” will earn 100× more likes than a balanced analysis of safety margins. The result is a distorted picture of reality in which every ingredient is a potential threat.

A few rules of critical thinking when assessing reports about EDCs:

  • An in vitro study ≠ an effect in the body — cells in a dish have no liver to metabolise the substance.
  • Detection in urine ≠ a harmful dose — biomonitoring confirms exposure, not risk.
  • An effect in rodents ≠ an effect in humans — the doses in animal studies are thousands of times higher than cosmetic exposure.
  • Correlation ≠ causation — many epidemiological studies show nothing more than co-occurrence.

If you want to know which ingredients in your cosmetics have documented endocrine activity, use the PurScore ingredient analyser. You'll get an assessment based on SCCS data and current regulations — not on TikTok scare stories.

Summary — common sense instead of panic

Endocrine-disrupting chemicals are a genuine scientific issue that deserves serious debate and ongoing research. But real-world exposure from cosmetics approved in the EU stays within the limits set by independent scientific committees. Rather than throwing all your cosmetics in the bin, it is worth learning to read the INCI list and make evidence-based decisions.

Check the ingredients of your cosmetic →

FAQ

BPA is not used as a cosmetic ingredient. The main sources of BPA exposure are food packaging, thermal receipts and can linings. Trace amounts may migrate from packaging, but it is not an ingredient in a cosmetic's formula.

The longer-chain phthalates — DEHP, DBP and BBP — have been banned from cosmetics in the EU since 2004 under Regulation 1223/2009 (Annex II). DEP (diethyl phthalate), used as a fragrance fixative, remains permitted.

The SCCS has assessed benzophenone-3 as safe at concentrations up to 6% in sunscreen products (opinion SCCS/1625/20). Its estrogenic activity is 10,000 to 1,000,000 times weaker than that of natural estradiol.

The margin of safety is the ratio between the dose at which no adverse effects are observed (NOAEL) and the estimated human exposure. An MoS ≥ 100 means that exposure is at least 100 times lower than the level considered safe in studies.

Want more articles like this?

Subscribe to our newsletter — free cosmetic ingredient tips, weekly.

Date protected per privacy policy.

Check products

Looking for cosmetics related to this topic? Compare ingredients and prices on PurScore.

0 products